Abeona Therapeutics Inc. - ABEO Net earnings per one share for the last twelve months

Abeona Therapeutics, Inc. (ABEO) - corporate logo

This chart shows the market EPS (TTM) for Abeona Therapeutics (ABEO) at -173.20. Abeona Therapeutics (ABEO) develops advanced cell restoration methods for individuals with rare skin pathologies. The company attracts leading biologists through a system of long-term options and grants. The ability to exercise pricing power over therapy costs will emerge following FDA certification, which will secure a monopoly position for the business.

ABEO: Abeona Therapeutics Inc. Net earnings per share for the last 12 months 02/11/2024 - 11/18/2026

Abeona Therapeutics Inc. - analytical breakdowns and key metrics (ABEO)

- issuer market value details:
Fundamental company valuation:ABEO - Abeona
Brand item of abeonatherapeutics.com

When assessing the resilience of Abeona Therapeutics (ABEO) to external shocks, it is critical to consider its dependence on third-party CRO partners and cryogenic logistics. The annual growth rate of EPS (TTM) measures the pace of change in net income per share, reflecting the capitalization's reaction to borrowing costs. This indicator allows investors to promptly evaluate the business's ability to service debt outside of quarterly reports. The stability of this metric confirms the reliability of the operating model in a high-interest-rate environment.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)